alpha-aminopyridine has been researched along with Migraine Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaplan, SR; Hoffmann, J; Meents, JE; Neeb, L; Reuter, U; Schuh-Hofer, S; Wickenden, A | 1 |
| Dworetzky, SI; Wua, YJ | 1 |
| Finlay, BR; Million, R; Whittington, JR | 1 |
| Krabbe, AA; Olesen, J | 1 |
1 review(s) available for alpha-aminopyridine and Migraine Disorders
| Article | Year |
|---|---|
Recent developments on KCNQ potassium channel openers.
Topics: Acrylamides; Aminopyridines; Benzamides; Carbamates; Epilepsy; Humans; Indoles; Ion Channel Gating; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Migraine Disorders; Oxindoles; Pain; Phenylenediamines; Potassium Channels, Voltage-Gated | 2005 |
2 trial(s) available for alpha-aminopyridine and Migraine Disorders
| Article | Year |
|---|---|
Clinical trial of flupirtine maleate in patients with migraine.
Topics: Acetaminophen; Administration, Oral; Adolescent; Adult; Aged; Aminopyridines; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain; Random Allocation; Sex Factors | 1984 |
Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms.
Topics: Aminopyridines; Cimetidine; Headache; Histamine; Humans; Migraine Disorders; Pyrilamine | 1980 |
1 other study(ies) available for alpha-aminopyridine and Migraine Disorders
| Article | Year |
|---|---|
Two TRPV1 receptor antagonists are effective in two different experimental models of migraine.
Topics: Aminopyridines; Animals; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Genes, fos; Male; Migraine Disorders; Piperazines; Rats; Rats, Sprague-Dawley; Treatment Outcome; TRPV Cation Channels; Up-Regulation | 2015 |